Search by Drug Name or NDC
NDC 64406-0017-01 Plegridy 125 ug/.5mL Details
Plegridy 125 ug/.5mL
Plegridy is a INTRAMUSCULAR INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is PEGINTERFERON BETA-1A.
MedlinePlus Drug Summary
Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginterferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2a may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2a may not prevent the spread of hepatitis C or hepatitis B to other people.
Related Packages: 64406-0017-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Peginterferon Alfa-2a Injection
Peginterferon beta-1a injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including the following: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Peginterferon beta-1a injection is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 64406-0017-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Peginterferon Beta-1a Injection
Product Information
NDC | 64406-0017 |
---|---|
Product ID | 64406-017_488569c2-1737-414d-9d48-0ad5567a38f6 |
Associated GPIs | 6240307530E521 |
GCN Sequence Number | 081976 |
GCN Sequence Number Description | peginterferon beta-1a SYRINGE 125MCG/0.5 INTRAMUSC |
HIC3 | H0E |
HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
GCN | 49258 |
HICL Sequence Number | 041331 |
HICL Sequence Number Description | PEGINTERFERON BETA-1A |
Brand/Generic | Brand |
Proprietary Name | Plegridy |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | peginterferon beta-1a |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAMUSCULAR |
Active Ingredient Strength | 125 |
Active Ingredient Units | ug/.5mL |
Substance Name | PEGINTERFERON BETA-1A |
Labeler Name | Biogen Inc. |
Pharmaceutical Class | Interferon beta [EPC], Interferon-beta [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA125499 |
Listing Certified Through | 2024-12-31 |
Package
NDC 64406-0017-01 (64406001701)
NDC Package Code | 64406-017-01 |
---|---|
Billing NDC | 64406001701 |
Package | 1 TRAY in 1 CARTON (64406-017-01) / 2 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE (64406-017-02) |
Marketing Start Date | 2021-01-29 |
NDC Exclude Flag | N |
Pricing Information | N/A |